Case number# PHEH2015US018692, is an initial spontaneous report from a consumer received on 21 Sep 2015. 
This report refers to a male patient of unknown age. Medical history and concomitant medication were not reported.
The patient received Gilenya (fingolimod) for an unknown indication (start date, dose, frequency and route of 
administration was unknown).
On an unknown date, the patient was tested positive for JC virus (JC virus test positive). No PML (progressive 
multifocal leukoencephalopathy) was reported.
Treatment with Gilenya was stopped on an unknown date and the patient was switched to injections (unspecified) 
immediately.
Print Time: 13-JUN-2016 09:36 AM If a field is blank, there is no data for that field Page 414 of 457
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
The outcome of the event JC virus test positive was unknown. The seriousness and causality assessment for JC 
virus test positive were not reported by the consumer.
The reporter did not give consent to contact.